[(8R)-8-[(1S,2R,5R,6R,9R,10R,13R,15S)-13-hydroxy-6,10-dimethyl-17,19-dioxo-18-phenyl-16,18,20-triazahexacyclo[13.5.2.01,9.02,6.010,15.016,20]docosa-11,21-dien-5-yl]-2-methylnonan-2-yl] acetate

C39H53N3O5 — CID 10032117

IUPAC[(8R)-8-[(1S,2R,5R,6R,9R,10R,13R,15S)-13-hydroxy-6,10-dimethyl-17,19-dioxo-18-phenyl-16,18,20-triazahexacyclo[13.5.2.01,9.02,6.010,15.016,20]docosa-11,21-dien-5-yl]-2-methylnonan-2-yl] acetate
SMILESCC(=O)OC(C)(C)CCCCC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@]23C=C[C@]2(C[C@@H](O)C=C[C@]12C)n1c(=O)n(-c2ccccc2)c(=O)n13
InChIInChI=1S/C39H53N3O5/c1-26(13-9-8-12-20-35(3,4)47-27(2)43)30-16-17-31-36(30,5)21-19-32-37(6)22-18-29(44)25-38(37)23-24-39(31,32)42-34(46)40(33(45)41(38)42)28-14-10-7-11-15-28/h7,10-11,14-15,18,22-24,26,29-32,44H,8-9,12-13,16-17,19-21,25H2,1-6H3/t26-,29+,30-,31-,32-,36-,37-,38-,39+/m1/s1
InChIKeyJOBHERZPRFWPHB-DNQUZRRWSA-N
MW643.87 g/mol
LogP6.47
Rot. Bonds9

About [(8R)-8-[(1S,2R,5R,6R,9R,10R,13R,15S)-13-hydroxy-6,10-dimethyl-17,19-dioxo-18-phenyl-16,18,20-triazahexacyclo[13.5.2.01,9.02,6.010,15.016,20]docosa-11,21-dien-5-yl]-2-methylnonan-2-yl] acetate

[(8R)-8-[(1S,2R,5R,6R,9R,10R,13R,15S)-13-hydroxy-6,10-dimethyl-17,19-dioxo-18-phenyl-16,18,20-triazahexacyclo[13.5.2.01,9.02,6.010,15.016,20]docosa-11,21-dien-5-yl]-2-methylnonan-2-yl] acetate (PubChem CID 10032117) has the molecular formula C39H53N3O5 and a molecular weight of 643.87 g/mol. Its IUPAC name is [(8R)-8-[(1S,2R,5R,6R,9R,10R,13R,15S)-13-hydroxy-6,10-dimethyl-17,19-dioxo-18-phenyl-16,18,20-triazahexacyclo[13.5.2.01,9.02,6.010,15.016,20]docosa-11,21-dien-5-yl]-2-methylnonan-2-yl] acetate.

Molecular Properties

Compound Name[(8R)-8-[(1S,2R,5R,6R,9R,10R,13R,15S)-13-hydroxy-6,10-dimethyl-17,19-dioxo-18-phenyl-16,18,20-triazahexacyclo[13.5.2.01,9.02,6.010,15.016,20]docosa-11,21-dien-5-yl]-2-methylnonan-2-yl] acetate
PubChem CID10032117
Molecular FormulaC39H53N3O5
Molecular Weight643.87 g/mol
Exact Mass643.40
IUPAC Name[(8R)-8-[(1S,2R,5R,6R,9R,10R,13R,15S)-13-hydroxy-6,10-dimethyl-17,19-dioxo-18-phenyl-16,18,20-triazahexacyclo[13.5.2.01,9.02,6.010,15.016,20]docosa-11,21-dien-5-yl]-2-methylnonan-2-yl] acetate
SMILESCC(=O)OC(C)(C)CCCCC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@]23C=C[C@]2(C[C@@H](O)C=C[C@]12C)n1c(=O)n(-c2ccccc2)c(=O)n13
InChIInChI=1S/C39H53N3O5/c1-26(13-9-8-12-20-35(3,4)47-27(2)43)30-16-17-31-36(30,5)21-19-32-37(6)22-18-29(44)25-38(37)23-24-39(31,32)42-34(46)40(33(45)41(38)42)28-14-10-7-11-15-28/h7,10-11,14-15,18,22-24,26,29-32,44H,8-9,12-13,16-17,19-21,25H2,1-6H3/t26-,29+,30-,31-,32-,36-,37-,38-,39+/m1/s1
InChIKeyJOBHERZPRFWPHB-DNQUZRRWSA-N
XLogP6.47
TPSA95.46 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds9
Heavy Atoms47
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500643.87
LogP ≤ 56.47
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(8R)-8-[(1S,2R,5R,6R,9R,10R,13R,15S)-13-hydroxy-6,10-dimethyl-17,19-dioxo-18-phenyl-16,18,20-triazahexacyclo[13.5.2.01,9.02,6.010,15.016,20]docosa-11,21-dien-5-yl]-2-methylnonan-2-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(8R)-8-[(1S,2R,5R,6R,9R,10R,13R,15S)-13-hydroxy-6,10-dimethyl-17,19-dioxo-18-phenyl-16,18,20-triazahexacyclo[13.5.2.01,9.02,6.010,15.016,20]docosa-11,21-dien-5-yl]-2-methylnonan-2-yl] acetate?
The IUPAC name of [(8R)-8-[(1S,2R,5R,6R,9R,10R,13R,15S)-13-hydroxy-6,10-dimethyl-17,19-dioxo-18-phenyl-16,18,20-triazahexacyclo[13.5.2.01,9.02,6.010,15.016,20]docosa-11,21-dien-5-yl]-2-methylnonan-2-yl] acetate (CID 10032117) is [(8R)-8-[(1S,2R,5R,6R,9R,10R,13R,15S)-13-hydroxy-6,10-dimethyl-17,19-dioxo-18-phenyl-16,18,20-triazahexacyclo[13.5.2.01,9.02,6.010,15.016,20]docosa-11,21-dien-5-yl]-2-methylnonan-2-yl] acetate.
What is the SMILES notation for [(8R)-8-[(1S,2R,5R,6R,9R,10R,13R,15S)-13-hydroxy-6,10-dimethyl-17,19-dioxo-18-phenyl-16,18,20-triazahexacyclo[13.5.2.01,9.02,6.010,15.016,20]docosa-11,21-dien-5-yl]-2-methylnonan-2-yl] acetate?
The canonical SMILES for [(8R)-8-[(1S,2R,5R,6R,9R,10R,13R,15S)-13-hydroxy-6,10-dimethyl-17,19-dioxo-18-phenyl-16,18,20-triazahexacyclo[13.5.2.01,9.02,6.010,15.016,20]docosa-11,21-dien-5-yl]-2-methylnonan-2-yl] acetate is CC(=O)OC(C)(C)CCCCC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@]23C=C[C@]2(C[C@@H](O)C=C[C@]12C)n1c(=O)n(-c2ccccc2)c(=O)n13.
What is the InChIKey of [(8R)-8-[(1S,2R,5R,6R,9R,10R,13R,15S)-13-hydroxy-6,10-dimethyl-17,19-dioxo-18-phenyl-16,18,20-triazahexacyclo[13.5.2.01,9.02,6.010,15.016,20]docosa-11,21-dien-5-yl]-2-methylnonan-2-yl] acetate?
The InChIKey is JOBHERZPRFWPHB-DNQUZRRWSA-N. The full InChI is InChI=1S/C39H53N3O5/c1-26(13-9-8-12-20-35(3,4)47-27(2)43)30-16-17-31-36(30,5)21-19-32-37(6)22-18-29(44)25-38(37)23-24-39(31,32)42-34(46)40(33(45)41(38)42)28-14-10-7-11-15-28/h7,10-11,14-15,18,22-24,26,29-32,44H,8-9,12-13,16-17,19-21,25H2,1-6H3/t26-,29+,30-,31-,32-,36-,37-,38-,39+/m1/s1.
What are the key properties of [(8R)-8-[(1S,2R,5R,6R,9R,10R,13R,15S)-13-hydroxy-6,10-dimethyl-17,19-dioxo-18-phenyl-16,18,20-triazahexacyclo[13.5.2.01,9.02,6.010,15.016,20]docosa-11,21-dien-5-yl]-2-methylnonan-2-yl] acetate?
[(8R)-8-[(1S,2R,5R,6R,9R,10R,13R,15S)-13-hydroxy-6,10-dimethyl-17,19-dioxo-18-phenyl-16,18,20-triazahexacyclo[13.5.2.01,9.02,6.010,15.016,20]docosa-11,21-dien-5-yl]-2-methylnonan-2-yl] acetate has a molecular weight of 643.87 g/mol, XLogP of 6.47, 9 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for [(8R)-8-[(1S,2R,5R,6R,9R,10R,13R,15S)-13-hydroxy-6,10-dimethyl-17,19-dioxo-18-phenyl-16,18,20-triazahexacyclo[13.5.2.01,9.02,6.010,15.016,20]docosa-11,21-dien-5-yl]-2-methylnonan-2-yl] acetate is sourced from PubChem (CID 10032117), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).